The stock price of GRI Bio Inc (NASDAQ: GRI) has dropped by -6.76 compared to previous close of 0.69. Despite this, the company has seen a fall of -27.37% in its stock price over the last five trading days. globenewswire.com reported 2024-11-14 that $13.9 million in gross proceeds raised since the beginning of 2024 extending expected cash runway into mid Q1 2025 and through interim data readout from GRI-0621 Phase 2a biomarker study
Is It Worth Investing in GRI Bio Inc (NASDAQ: GRI) Right Now?
The 36-month beta value for GRI is also noteworthy at -2.05. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GRI is 8.92M, and at present, short sellers hold a 10.37% of that float. The average trading volume of GRI on November 21, 2024 was 4.40M shares.
GRI’s Market Performance
GRI stock saw a decrease of -27.37% in the past week, with a monthly decline of -34.12% and a quarterly a decrease of 27.72%. The volatility ratio for the week is 17.42%, and the volatility levels for the last 30 days are 19.98% for GRI Bio Inc (GRI). The simple moving average for the past 20 days is -23.37% for GRI’s stock, with a -84.30% simple moving average for the past 200 days.
GRI Trading at 1.68% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.40% of loss for the given period.
Volatility was left at 19.98%, however, over the last 30 days, the volatility rate increased by 17.42%, as shares sank -20.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.25% upper at present.
During the last 5 trading sessions, GRI fell by -27.37%, which changed the moving average for the period of 200-days by -96.28% in comparison to the 20-day moving average, which settled at $0.8338. In addition, GRI Bio Inc saw -98.18% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRI
Current profitability levels for the company are sitting at:
- -1.6 for the present operating margin
- 1.0 for the gross margin
The net margin for GRI Bio Inc stands at -1.53. The total capital return value is set at -1.79. Equity return is now at value -280.75, with -167.58 for asset returns.
Currently, EBITDA for the company is -10.9 million with net debt to EBITDA at 0.72. When we switch over and look at the enterprise to sales, we see a ratio of -0.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.10.
Conclusion
In summary, GRI Bio Inc (GRI) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
